Vertex Pharmaceuticals unveiled impressive long-term results for its CRISPR/Cas9 gene therapy, PrCASGEVY, at the EHA Congress ...

This was the stock's third consecutive day of gains.

Vertex Pharmaceuticals scored a major win with the EU approval of ALYFTREK, expanding its cystic fibrosis treatment access in ...

This was the stock's second consecutive day of gains.

A legislative ban on pharma ads, a tool for companies to amplify messaging on drugs, including for precision medicines, is ...

Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” first quarter 2025 ...

What does the fracturing of vaccine advice and policy mean for the U.S. health care ecosystem? Will the potential head of the ...

Collin Morikawa, ranked 5th in the world, is seeking his first PGA Tour victory since October 2023 at the Rocket Classic in ...

TUESDAY, June 24, 2025 (HealthDay News) — A single infusion of a new stem cell-based treatment may have helped 10 out of 12 ...

Congressional lawmakers are trading millions in pharmaceutical stocks as the Trump administration vies to overhaul the ...

One-year data suggest allogeneic stem cell-derived islet-cell therapy could become a future option for those with type 1 ...